About a quarter of women experience moderate to severe pain for many years after their treatment ends. In many cases, it's a type of pain that is challenging to treat, with few or no effective options.
A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood -- and it can support the cells' growth for further analysis.
Michigan Medicine has begun offering a new urine test called Mi-Prostate Score to improve on PSA screening for prostate cancer. The test incorporates three specific markers that could indicate cancer and studies have shown that the combination is far more accurate than PSA alone.
Recent studies have suggested that an informed patient will be less likely to choose a more-extensive treatment than what the doctor recommends but a recent study by University of Michigan Rogel Cancer Cetner researchers have found that's not necessarily the case.
MENU